KR20230121827A - Nav1.8 전압-게이팅 나트륨 채널의 억제 및 Nav1.8매개 질환의 치료에 유용한 화학적 화합물 - Google Patents
Nav1.8 전압-게이팅 나트륨 채널의 억제 및 Nav1.8매개 질환의 치료에 유용한 화학적 화합물 Download PDFInfo
- Publication number
- KR20230121827A KR20230121827A KR1020237023878A KR20237023878A KR20230121827A KR 20230121827 A KR20230121827 A KR 20230121827A KR 1020237023878 A KR1020237023878 A KR 1020237023878A KR 20237023878 A KR20237023878 A KR 20237023878A KR 20230121827 A KR20230121827 A KR 20230121827A
- Authority
- KR
- South Korea
- Prior art keywords
- pain
- compound
- pharmaceutically acceptable
- acceptable salt
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063127341P | 2020-12-18 | 2020-12-18 | |
| US63/127,341 | 2020-12-18 | ||
| PCT/EP2021/086101 WO2022129283A1 (en) | 2020-12-18 | 2021-12-16 | Chemical compounds useful for inhibiting nav1.8 voltage-gated sodium channels and treating nav1.8 mediated diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20230121827A true KR20230121827A (ko) | 2023-08-21 |
Family
ID=79025144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237023878A Pending KR20230121827A (ko) | 2020-12-18 | 2021-12-16 | Nav1.8 전압-게이팅 나트륨 채널의 억제 및 Nav1.8매개 질환의 치료에 유용한 화학적 화합물 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP4262978A1 (https=) |
| JP (1) | JP2024502231A (https=) |
| KR (1) | KR20230121827A (https=) |
| CN (1) | CN116710463A (https=) |
| AU (1) | AU2021403606B2 (https=) |
| CA (1) | CA3202328A1 (https=) |
| CL (1) | CL2023001750A1 (https=) |
| CO (1) | CO2023008049A2 (https=) |
| IL (1) | IL303795A (https=) |
| MX (1) | MX2023007244A (https=) |
| PH (1) | PH12023551406A1 (https=) |
| SA (1) | SA523441263B1 (https=) |
| WO (1) | WO2022129283A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2931550C (en) * | 2013-12-13 | 2023-09-26 | Vertex Pharmaceuticals Incorporated | Prodrugs of pyridone amides useful as modulators of sodium channels |
| GB201322602D0 (en) * | 2013-12-19 | 2014-02-05 | Almac Discovery Ltd | Pharmaceutical compounds |
| EP3625214B1 (en) * | 2017-05-16 | 2022-07-06 | Vertex Pharmaceuticals Incorporated | Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels |
| MX2021015605A (es) * | 2019-06-27 | 2022-02-16 | Glaxosmithkline Ip Dev Ltd | Compuestos 2,3-dihidroquinazolin como inhibidores nav1.8. |
-
2021
- 2021-12-16 EP EP21831047.2A patent/EP4262978A1/en active Pending
- 2021-12-16 WO PCT/EP2021/086101 patent/WO2022129283A1/en not_active Ceased
- 2021-12-16 JP JP2023536951A patent/JP2024502231A/ja not_active Ceased
- 2021-12-16 KR KR1020237023878A patent/KR20230121827A/ko active Pending
- 2021-12-16 MX MX2023007244A patent/MX2023007244A/es unknown
- 2021-12-16 AU AU2021403606A patent/AU2021403606B2/en active Active
- 2021-12-16 PH PH1/2023/551406A patent/PH12023551406A1/en unknown
- 2021-12-16 IL IL303795A patent/IL303795A/en unknown
- 2021-12-16 CN CN202180085151.XA patent/CN116710463A/zh active Pending
- 2021-12-16 CA CA3202328A patent/CA3202328A1/en active Pending
-
2023
- 2023-06-15 CL CL2023001750A patent/CL2023001750A1/es unknown
- 2023-06-18 SA SA523441263A patent/SA523441263B1/ar unknown
- 2023-06-21 CO CONC2023/0008049A patent/CO2023008049A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2023007244A (es) | 2023-06-29 |
| CL2023001750A1 (es) | 2024-01-19 |
| CO2023008049A2 (es) | 2023-06-30 |
| JP2024502231A (ja) | 2024-01-18 |
| SA523441263B1 (ar) | 2025-01-07 |
| AU2021403606B2 (en) | 2024-11-14 |
| PH12023551406A1 (en) | 2024-01-22 |
| IL303795A (en) | 2023-08-01 |
| AU2021403606A1 (en) | 2023-06-22 |
| WO2022129283A1 (en) | 2022-06-23 |
| EP4262978A1 (en) | 2023-10-25 |
| CN116710463A (zh) | 2023-09-05 |
| CA3202328A1 (en) | 2022-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7701880B2 (ja) | ＮａＶ１．８阻害剤としての２，３－ジヒドロキナゾリン化合物 | |
| JP7039802B2 (ja) | Ｒｈｏ－関連プロテインキナーゼ阻害剤、ｒｈｏ－関連プロテインキナーゼ阻害剤を含む医薬組成物、当該医薬組成物の調製方法及び使用 | |
| JP5795630B2 (ja) | 抗癌及び抗増殖活性を示すシクロプロピルジカルボキサミド及び類似体 | |
| KR100737090B1 (ko) | 축합 이미다졸륨 유도체 | |
| US9783522B2 (en) | 2-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereof | |
| CN116601153B (zh) | 作为nav1.8抑制剂的含氮2,3-二氢喹唑啉酮化合物 | |
| KR20210003807A (ko) | Egfr 3중 돌연변이 억제제로서의 퀴나졸린 화합물 및 이의 응용 | |
| KR20220105425A (ko) | 티아졸로피리딘 또는 이의 약학적으로 허용 가능한 염 및 이의 용도 | |
| CA3253274A1 (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH THE ACTIVITY OF THE LPA RECIPIENT | |
| JP2017078039A (ja) | 新規２−アミノ−ピリジン又は２−アミノ−ピリミジン誘導体を有効成分として含有する医薬組成物 | |
| CA3204891A1 (en) | Pyridine derivatives as modulators of sortilin activity | |
| US20250084112A1 (en) | Chemical Compounds Useful for Inhibiting Nav1.8 Voltage-Gated Sodium Channels and Treating Nav1.8 Mediated Diseases | |
| KR20230121827A (ko) | Nav1.8 전압-게이팅 나트륨 채널의 억제 및 Nav1.8매개 질환의 치료에 유용한 화학적 화합물 | |
| US20230416287A1 (en) | Chemical Compounds | |
| CA3212863A1 (en) | Indoline derivatives as ddr1 and ddr2 inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20230713 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20241213 Comment text: Request for Examination of Application |